share_log

HC Wainwright & Co. Reiterates Buy on Plus Therapeutics, Maintains $8 Price Target

Benzinga ·  Aug 16 20:19  · Ratings

HC Wainwright & Co. analyst Sean Lee reiterates Plus Therapeutics (NASDAQ:PSTV) with a Buy and maintains $8 price target.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment